These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 12119342)

  • 1. Identification of the lateral interaction surfaces of human histocompatibility leukocyte antigen (HLA)-DM with HLA-DR1 by formation of tethered complexes that present enhanced HLA-DM catalysis.
    Stratikos E; Mosyak L; Zaller DM; Wiley DC
    J Exp Med; 2002 Jul; 196(2):173-83. PubMed ID: 12119342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disruption of hydrogen bonds between major histocompatibility complex class II and the peptide N-terminus is not sufficient to form a human leukocyte antigen-DM receptive state of major histocompatibility complex class II.
    Schulze MS; Anders AK; Sethi DK; Call MJ
    PLoS One; 2013; 8(7):e69228. PubMed ID: 23976922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A recombinant single-chain human class II MHC molecule (HLA-DR1) as a covalently linked heterotrimer of alpha chain, beta chain, and antigenic peptide, with immunogenicity in vitro and reduced affinity for bacterial superantigens.
    Zhu X; Bavari S; Ulrich R; Sadegh-Nasseri S; Ferrone S; McHugh L; Mage M
    Eur J Immunol; 1997 Aug; 27(8):1933-41. PubMed ID: 9295029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced catalytic action of HLA-DM on the exchange of peptides lacking backbone hydrogen bonds between their N-terminal region and the MHC class II alpha-chain.
    Stratikos E; Wiley DC; Stern LJ
    J Immunol; 2004 Jan; 172(2):1109-17. PubMed ID: 14707085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA-DO as the optimizer of epitope selection for MHC class II antigen presentation.
    Poluektov YO; Kim A; Hartman IZ; Sadegh-Nasseri S
    PLoS One; 2013; 8(8):e71228. PubMed ID: 23951115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating the Role of HLA-DM in MHC Class II-Peptide Association Reactions.
    Yin L; Maben ZJ; Becerra A; Stern LJ
    J Immunol; 2015 Jul; 195(2):706-16. PubMed ID: 26062997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cutting edge: HLA-DM functions through a mechanism that does not require specific conserved hydrogen bonds in class II MHC-peptide complexes.
    Zhou Z; Callaway KA; Weber DA; Jensen PE
    J Immunol; 2009 Oct; 183(7):4187-91. PubMed ID: 19767569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The structure of an intermediate in class II MHC maturation: CLIP bound to HLA-DR3.
    Ghosh P; Amaya M; Mellins E; Wiley DC
    Nature; 1995 Nov; 378(6556):457-62. PubMed ID: 7477400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA-DM targets the hydrogen bond between the histidine at position beta81 and peptide to dissociate HLA-DR-peptide complexes.
    Narayan K; Chou CL; Kim A; Hartman IZ; Dalai S; Khoruzhenko S; Sadegh-Nasseri S
    Nat Immunol; 2007 Jan; 8(1):92-100. PubMed ID: 17143275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Masking of a cathepsin G cleavage site in vivo contributes to the proteolytic resistance of major histocompatibility complex class II molecules.
    Burster T; Macmillan H; Hou T; Schilling J; Truong P; Boehm BO; Zou F; Lau K; Strohman M; Schaffert S; Busch R; Mellins ED
    Immunology; 2010 Jul; 130(3):436-46. PubMed ID: 20331476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stabilization of soluble, low-affinity HLA-DM/HLA-DR1 complexes by leucine zippers.
    Busch R; Pashine A; Garcia KC; Mellins ED
    J Immunol Methods; 2002 May; 263(1-2):111-21. PubMed ID: 12009208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Thermodynamic Mechanism of Peptide-MHC Class II Complex Formation Is a Determinant of Susceptibility to HLA-DM.
    Ferrante A; Templeton M; Hoffman M; Castellini MJ
    J Immunol; 2015 Aug; 195(3):1251-61. PubMed ID: 26116504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formation of two peptide/MHC II isomers is catalyzed differentially by HLA-DM.
    Belmares MP; Busch R; Mellins ED; McConnell HM
    Biochemistry; 2003 Jan; 42(3):838-47. PubMed ID: 12534297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA-DM catalytically enhances peptide dissociation by sensing peptide-MHC class II interactions throughout the peptide-binding cleft.
    Reyes-Vargas E; Barker AP; Zhou Z; He X; Jensen PE
    J Biol Chem; 2020 Mar; 295(10):2959-2973. PubMed ID: 31969393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding affinity independent contribution of peptide length to the stability of peptide-HLA-DR complexes in live antigen presenting cells.
    Siklodi B; Vogt AB; Kropshofer H; Falcioni F; Molina M; Bolin DR; Campbell R; Hämmerling GJ; Nagy ZA
    Hum Immunol; 1998 Aug; 59(8):463-71. PubMed ID: 9712349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphism at beta 85 and not beta 86 of HLA-DR1 is predominantly responsible for restricting the nature of the anchor side chain: implication for concerted effects of class II MHC polymorphism.
    Wu S; Gorski J
    Int Immunol; 1997 Oct; 9(10):1495-502. PubMed ID: 9352354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The kinetic basis of peptide exchange catalysis by HLA-DM.
    Zarutskie JA; Busch R; Zavala-Ruiz Z; Rushe M; Mellins ED; Stern LJ
    Proc Natl Acad Sci U S A; 2001 Oct; 98(22):12450-5. PubMed ID: 11606721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human histocompatibility leukocyte antigen (HLA)-DM edits peptides presented by HLA-DR according to their ligand binding motifs.
    van Ham SM; Grüneberg U; Malcherek G; Bröker I; Melms A; Trowsdale J
    J Exp Med; 1996 Nov; 184(5):2019-24. PubMed ID: 8920889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetic analysis of peptide loading onto HLA-DR molecules mediated by HLA-DM.
    Vogt AB; Kropshofer H; Moldenhauer G; Hämmerling GJ
    Proc Natl Acad Sci U S A; 1996 Sep; 93(18):9724-9. PubMed ID: 8790398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The N-terminal region of photocleavable peptides that bind HLA-DR1 determines the kinetics of fragment release.
    Negroni MP; Stern LJ
    PLoS One; 2018; 13(7):e0199704. PubMed ID: 29965980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.